Under Which Brand Names is Tirzepatide Available in the U.S.?
| Brand Name | Primary Use |
|---|---|
| Mounjaro | Treatment of Type 2 Diabetes (used with diet & exercise to control blood sugar) |
| Zepbound | Weight loss & treatment of obstructive sleep apnea in patients with obesity |
Key Facts
- Tirzepatide is given via subcutaneous injections.
- It acts as a GIP receptor and GLP-1 receptor agonist.
- Helps reduce blood sugar, aids in weight loss, and treats moderate to severe OSA in obese patients.
- Available only with a doctor’s prescription.
Tirzepatide is an antidiabetic medication used to treat type 2 diabetes and for weight loss. Tirzepatide is administered via subcutaneous injections. In the United States, it is sold under the brand name Mounjaro for diabetes treatment and Zepbound for weight loss and treatment of obstructive sleep apnea.
